We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Preferential Attack on Cancer by Selected SH Inhibitors

Frances E. Knock, PhD, MD; Raymond M. Galt, MD; Y.T. Oester, MD, PhD
JAMA. 1970;214(1):146. doi:10.1001/jama.1970.03180010086025.
Text Size: A A A
Published online


To the Editor.—  In sensitivity tests on hundreds of human cancers, selected sulfhydryl (SH) inhibitors have shown greater effect against tumors than against normal tissues. Clinically, SH inhibitors have caused the regression of a variety of human carcinomas, sarcomas, and lymphomas without injury to wound healing and with minimal injury to hematologic status and even improvement in some patients. The drug regimens are started within 24 to 48 hours of major cancer surgery, such as palliative bowel resection or pelvic exenteration. In two series totalling over 100 patients, the majority of patients whose tumors could be measured objectively received objective benefit from chemotherapy with the SH inhibitor oxophenarsine plus adjuncts, alone or in combination with other anticancer drugs which were picked in accord with sensitivity tests on each patient's own cancer.1From the work of Di Paolo2 and Kondo3 the sensitivity tests are now known to be


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.